The global Oral Proteins & Peptides Market size was estimated at USD 7,350 million in 2023 and is projected to reach USD 33,318.8 million in 2030 at a CAGR of 24.10 % during the forecast period 2024-2030.
The oral proteins and peptides market refer to the development and utilization of proteins and peptides delivered orally as therapeutic agents or nutritional supplements. These biomolecules are critical in various medical and healthcare applications, offering solutions for metabolic disorders, malnutrition, and chronic diseases. The market is gaining prominence as the demand for non-injection-based treatments increases, making oral protein and peptide formulations an attractive alternative to conventional injectable therapies. This segment benefits from advances in drug delivery technologies, allowing for better absorption and efficacy of orally administered proteins and peptides.
The market scope is vast, covering a wide range of applications, including healthcare, sports nutrition, and clinical nutrition. In healthcare, oral proteins and peptides are utilized for treating diseases such as diabetes, cancer, and gastrointestinal disorders, while in sports and fitness, they are used to support muscle growth and recovery. The rising awareness of the benefits of proteins and peptides in promoting overall health and well-being has expanded their reach beyond medical use into general wellness. With increasing consumer interest in functional foods and supplements, the market for oral proteins and peptides is expected to see continued growth across various sectors.
Several trends are influencing the oral proteins and peptides market, including the growing preference for oral drug delivery systems over injectable alternatives, advancements in peptide synthesis, and the rising adoption of personalized medicine. The development of new peptide-based drugs, combined with innovations in encapsulation technologies to enhance bioavailability, has significantly boosted the market. Additionally, the rising consumer demand for plant-based and natural protein sources is prompting the development of alternative oral protein formulations that cater to dietary preferences and vegan lifestyles.
The key drivers of the oral proteins and peptides market include the increasing prevalence of chronic diseases, the growing demand for dietary supplements, and the technological advancements in oral protein delivery systems. With a rising global focus on preventative healthcare and healthier lifestyles, there is a surge in the use of protein and peptide-based products for both therapeutic and nutritional purposes. Additionally, the expansion of the pharmaceutical and biotechnology industries, along with the increasing investments in research and development, continues to fuel innovation and market growth in this segment.
Experts in the Oral Proteins & Peptides Market highlight several key trends driving growth and innovation. The oral proteins and peptides market is expanding due to the growing demand for non-injection-based therapies and nutritional supplements. These biomolecules are increasingly used in healthcare for treating chronic diseases, in sports nutrition for muscle growth, and in general wellness. Advancements in drug delivery technologies, better absorption methods, and innovations in peptide synthesis are driving the market, along with the rising preference for plant-based and natural protein sources. Key factors such as the increasing prevalence of chronic conditions, the demand for dietary supplements, and ongoing research in oral protein delivery systems are fuelling market growth across various sectors.
North America to Dominate the Market